Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

NCT01682876 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

715

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Disease
Infections, Meningococcal

Interventions

BIOLOGICAL: MenACWY-CRM

Sponsor

GlaxoSmithKline